Studies the Ion endoluminal system in people with lung nodules or lung cancer
Collects real-world data on the Ion device used to examine lung nodules.
Plain-language title generated from the registry record
Registry title: European Real-World Registry for Use of the Ion Endoluminal System
Key facts
- Where
- Berlin, Hemer, and Wiesbaden, GermanySee the 3 sites
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who are planned to have a lung lesion biopsy or localization procedure with the Ion endoluminal system.
- Age
- 18 years or older
- Sex
- All sexes can join.
Main reasons for not taking part
- Taking part in another interventional study or a study with investigational agents that would interfere with this one
- Pregnant or breast feeding
- Legally incapacitated, in a court-ordered institution, or part of a known vulnerable population
- Not willing to follow the study requirements after the procedure
- The investigator decides that taking part is not in the patient's interest
Read by machine on 9 November 2026.
Where in Germany
- Helios Klinikum Emil von BehringBerlin, GermanyTaking people
- DGD Lungenklining HemerHemer, GermanyTaking people
- Helios Dr. Horst Schmidt KlinikenWiesbaden, GermanyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Intuitive Surgical
- Trial code
- NCT06923774
- Record updated
- 9 October 2026
- Original description
The objective of this study is to collect collect real-world data for the Ion endoluminal system.Read full original descriptionShow less
A European Multi-Center, Prospective, Single-Arm, Observational Study to Evaluate Real-World Outcomes for the Ion Endoluminal System
The objective of this study is to collect collect real-world data for the Ion endoluminal system.
Inclusion: Patient is aged 18 years or older at time of consent; Patient is planned to undergo a lung lesion biopsy(s) and/or localization procedure(s) utilizing the Ion endoluminal system; Patient is willing and able to give written informed consent for clinical study participation.
Exclusion: Patient is participating in an interventional research study or research study with investigational agents with an unknown safety profile that would interfere with participation in this study or study results; Female patient that is pregnant or breast feeding as determined by standard site practices; Patient is legally incapacitated or in a legal/court ordered institution or is part of a known vulnerable population, including but not limited to dependency on the sponsor, hospital or study doctor; Patient is not willing to comply with post-procedure study participation requirements; Investigator, in their professional opinion, has decided that it is in the patient's best interest to not participate in the clinical study.